The conventional detection of proteins by imaging employs fluorophores or antibodies directed at individual proteins. However, this methodology cannot be upscaled and employed in a high-throughput omics approach.
The biodegradability of drugs was previously considered an environmental issue. Now Leuphana, together with leading pharmaceutical companies, is a partner in the EU project “Priorisation and Risk Evaluation of Medicines in the Environment” (PREMIER).
The development of cost-effective, reliable, and high-performance battery cells will be essential to strategic sectors in Europe such as the automotive industry (electro-mobility) and the electric power sector.
In an effort to bring science and society together in Europe, and consequently increase the continent’s international competitiveness, STEM (Science, Technology, Engineering and Mathematics) education must be more relatable to European youths to raise their interests and involvement in STEM careers.
The HPEM2GAS- project is developing a low-cost PEM electrolyzer optimized for grid management. By stacking and balancing the plant innovations, a six-month field test of an advanced 180-300kW PEM electrolyzer will be conducted.